Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF)...
94 insider purchases on record · latest filing 2025-12-15.
Insiders have also filed 193 sale transactions at VERA.